Literature DB >> 32529725

The Fourth International Workshop on Clinical Transplant Tolerance.

Fadi Issa1, Samuel Strober2, Joseph R Leventhal3, Tatsuo Kawai4, Dixon B Kaufman5, Josh Levitsky3, Megan Sykes6, Valeria Mas7, Kathryn J Wood1, Nancy Bridges8, Lisbeth A Welniak9, Sindhu Chandran10, Joren C Madsen11, Peter Nickerson12, Anthony J Demetris13, Fadi G Lakkis14, Angus W Thomson14.   

Abstract

The International Workshop on Clinical Transplant Tolerance is a biennial meeting that aims to provide an update on the progress of studies of immunosuppression minimization or withdrawal in solid organ transplantation. The Fourth International Workshop on Clinical Tolerance was held in Pittsburgh, Pennsylvania, September 5-6, 2019. This report is a summary of presentations on the status of clinical trials designed to minimize or withdraw immunosuppressive drugs in kidney, liver, and lung transplantation without subsequent evidence of rejection. All protocols had in common the use of donor or recipient cell therapy combined with organ transplantation. The workshop also included presentations of mechanistic studies designed to improve understanding of the cellular and molecular basis of tolerance and to identify potential predictors/biomarkers of tolerance. Strategies to enhance the safety of hematopoietic cell transplantation and to improve patient selection/risk stratification for clinical trials were also discussed.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; clinical trial; immune regulation; immunosuppression/immune modulation; kidney transplantation/nephrology; liver transplantation/hepatology; tolerance: chimerism; tolerance: clinical

Mesh:

Substances:

Year:  2020        PMID: 32529725     DOI: 10.1111/ajt.16139

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

Review 1.  Update on immunosuppressive strategies in intestinal transplantation.

Authors:  Jonathan Merola; Abrar Shamim; Joshua Weiner
Journal:  Curr Opin Organ Transplant       Date:  2022-04-01       Impact factor: 2.640

2.  Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function.

Authors:  Anil Dangi; Irma Husain; Collin Z Jordan; Shuangjin Yu; Naveen Natesh; Xiling Shen; Jean Kwun; Xunrong Luo
Journal:  J Am Soc Nephrol       Date:  2022-08-16       Impact factor: 14.978

Review 3.  Strategies for Liver Transplantation Tolerance.

Authors:  Filip Cvetkovski; J Mark Hexham; Erik Berglund
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

4.  Beyond kidney dialysis and transplantation: what's on the horizon?

Authors:  Hamid Rabb; Kyungho Lee; Chirag R Parikh
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

5.  Modeling the Potential of Treg-Based Therapies for Transplant Rejection: Effect of Dose, Timing, and Accumulation Site.

Authors:  Maya M Lapp; Guang Lin; Alexander Komin; Leah Andrews; Mei Knudson; Lauren Mossman; Giorgio Raimondi; Julia C Arciero
Journal:  Transpl Int       Date:  2022-04-11       Impact factor: 3.842

Review 6.  Transplant Tolerance, Not Only Clonal Deletion.

Authors:  Bruce M Hall; Nirupama D Verma; Giang T Tran; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

Review 7.  Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.

Authors:  Manuel Alfredo Podestà; Megan Sykes
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

8.  Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive.

Authors:  Yasmin R Mohseni; Adeel Saleem; Sim L Tung; Caroline Dudreuilh; Cameron Lang; Qi Peng; Alessia Volpe; George Adigbli; Amy Cross; Joanna Hester; Farzin Farzaneh; Cristiano Scotta; Robert I Lechler; Fadi Issa; Gilbert O Fruhwirth; Giovanna Lombardi
Journal:  Eur J Immunol       Date:  2021-08-08       Impact factor: 6.688

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.